Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 873630 LONDON, X0
Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$28,949,535
+$9,892,525 QoQ
Shares Held
961,140
+57.4% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Dec 31, 2025
CallValue
$1,775,849
CallShares
56,900
PutValue
$333,947
PutShares
10,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $402,454,379 across 27 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,063,170 $243,887,321
2 UTHR
UNITED THERAPEUTICS Corp
 119,235 $70,703,969
3 TEVA
Teva Pharmaceutical Industries Ltd
This page 		961,140 $28,949,535
4 NBIX
Neurocrine Biosciences Inc
 184,222 $24,269,403
5 VTRS
Viatris Inc
 1,715,900 $23,181,805
6 HIMS
Hims & Hers Health, Inc.
 84,159 $1,747,140
7 ALKS
Alkermes plc.
 48,337 $1,709,196
8 RDY
Dr Reddys Laboratories Ltd
 78,293 $1,084,357

All Filings in TEVA

Export CSV
40 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,949,535 961,140
2025-12-31 $19,057,010 610,606
2025-12-31 $333,947 10,700
2025-12-31 $1,775,849 56,900
2025-09-30 $3,809,720 188,600
2025-09-30 $826,180 40,900
2025-09-30 $29,869,658 1,478,696
2025-06-30 $23,738,176 1,416,359
2025-06-30 $531,292 31,700
2025-06-30 $2,247,516 134,100
2025-03-31 $628,633 40,900
2025-03-31 $21,259,352 1,383,172
2025-03-31 $2,898,782 188,600
2024-12-31 $12,370,808 561,289
2024-09-30 $9,571,034 531,134
2024-06-30 $12,324,080 758,405
2024-03-31 $21,030,333 1,490,456
2023-12-31 $16,674,537 1,597,178
2023-09-30 $4,755,331 466,209
2023-06-30 $2,340,482 310,821
2023-03-31 $2,713,268 306,584
2022-12-31 $1,729,779 189,669
2022-09-30 $2,093,461 259,413
2022-06-30 $3,128,912 416,079
2022-03-31 $3,199,810 340,768
2021-12-31 $401,301 50,100
2021-12-31 $3,127,239 390,417
2021-09-30 $3,516,372 361,024
2021-09-30 $487,974 50,100
2021-06-30 $525,690 53,100
2021-06-30 $3,408,203 344,263
2021-03-31 $924,354 80,100
2021-03-31 $4,435,697 384,376
2020-12-31 $3,345,585 346,693
2020-12-31 $1,260,290 130,600
2020-09-30 $2,371,150 263,169
2020-09-30 $460,411 51,100
2020-06-30 $2,379,257 192,965
2020-03-31 $5,475,912 609,790
2020-03-31 $260,420 29,000

Report a Problem

Category
Description
Email (optional, for follow-up)